The RB/E2F pathway is deregulated in many cancers [40,41] and overexpression of E2F1 also prevents androgen-withdrawal-mediated growth arrest and high levels of E2F1 expression represses neuroendocrine differentiation of androgen independent cells [20]. The gene discussed is E2F1; the disease is cancer.